ANFARM Presentation
ANFARM Presentation
ANFARM Presentation
Pharmaceuticals
Since 1967
ANFARM HELLAS S.A. was founded in
1967 by Mr. Apostolos Nicolaou, Chairman of
the Board of Directors to this day.
A p o s t o lo s N ic o la o u
C h a ir m a n
D im it r i N ic o a lo u
V ic e - P r e s id e n t
P la n t D ir e c t o r
E u g e n ia N ic o la o u
M a n a g in g & C o m m e r c ia l
D ir e c t o r
Headquarters
Administration offices and distribution
warehouse are located in the city of Athens.
ANFARM HELLAS S.A.
K.Paleologou & Perikleous 27
15232 Halandri, Athens - Hellas
Tel: 210-6831632
Fax: 210-6836540
e-mail: [email protected]
Production Facilities
The production facilities are built in a pollutionfree area, Schimatari of Viotia, about 60 km from
Athens, the capital of Hellas.
The plants
The plants have been built on the
companys owned land of 20.000 m, with
manufacturing facilities totaling 4.160 m
Plant A: 2.500 m (main)
Plant B: 1400 m (new)
Plant C: 1100 m (new)
The plants
1967 Foundation.
1969 Construction of the plant.
1979-81 Merger with Synthelabo France.
1989 Renovation of the Plant
1992 Creation of lyophilization dept.
1996 Renovation of the Sterile rooms
1997 ISO 9002 Certified
1999 Construction of 2 new plants
Our philosophy
To develop and produce high-quality generic
drugs at competitive cost, for both the
domestic and international markets.
To follow criteria and methods in order to
demonstrate and record the equivalence of
these generic products compared to the
original proprietary preparations.
We see Generics globally as an equivalent
therapeutic alternative which contributes to
cost reduction - without any loss of quality.
Our aim
Our main aim is to become one of the
leading Greek Pharmaceutical
Manufacturers.
Objectives
Maximize our sales in the domestic
market.
Increase our sales in foreign
markets (exports).
Contract manufacture for Hellenic
and other European companies.
Establish additional relationships
with international companies for
licensing.
Strategies
To achieve high production quality.
To specialize in production (new investments:
lyophilized products, sterile liquids,
cephalosporines).
To constantly renovate the existing facilities with
new instruments and machinery.
To maintain a continuous updated QA and QC
system.
To develop new formulations, new registrations (4
to 5 products per year).
Strategies
To maintain a high standard and dedicated staff.
To provide the resources and tools to our staff.
To maintain a good level of communication, among
the management and the employees of the Company.
To spread, evenly, information throughout the
Company about decisions of the management, new
investments, new cooperations and new projects in
general.
To utilize existing foreign markets (new registrations)
To explore new markets.
ANFARM s chart
V ic e -P re s id e n t
& P la n t D ire c to r
D . N ic o la o u
T e c n ic a l D ire c to r
H . G a k is
P ro d u c tio n
G .F o to p o u lo s
M ic ro b io lo g ic a l
C o n tro ls
A . Z am anou
Q u a lity C o n tro l
A . N ic o lo v ie n i
A n a ly tic a l
C o n tro ls
E . S p y ra k is
R & D
G . G ia n n a c o p o u lo u
A n a ly tic a l
C o n tro ls
P . K a p o u la
Q u a lity A s s u ra n c e
H . G a k is
D o c u m e n ta tio n
M anager
K . T a la m b e k o u
Personnel
The total number of persons working in the Production
Department, Quality Control Laboratory, Quality
Assurance and Packaging Department is 47.
9 persons comprise the scientific team.
1 Pharmacist - Plant Director
1 Chemist - Technical Director
3 Chemist - Production
2 Chemists - Quality Control
1 Chemist - Quality Assurance
1 Chemist - R & D
1 Biologist - Microbiological Laboratory
1 Engineer - Maintenance
Personnel
Quality Control = 6 persons
Quality Assurance = 4 persons
Production = 48 persons
R & D = 2 persons
Maintenance = 5 persons
Administration = 6 persons
Regulatory affairs
Applications and follow up of stages for the
registration of new products in the domestic
and overseas markets.
Continuous appraisal of information about
the law, regulations and patent requirements
applicable in different countries.
Traveling to meet with Agents and contact
Health Authorities abroad.
Hellenic Market
ANFARMs exports
Exports %
100
90
80
70
60
50
40
30
20
10
0
Exports
Domestic
1998
1999
2000
2001
2002
2003
Manufacturing Products
Carefully selected products for the
treatment of serious health problems,
merchandised under the companys name.
Products manufactured for third parties.
Contract manufacturing
agreements (GR)
Minerva - Faran - Kleva - Bros
Viostam - Adelco - Relyo - IFET
Finixfarm - Vocate - Medinova
Leovan - Coper - Remedina - Coup
Rafarm - Proel - Antor
Contract manufacturing
agreements internationally
Medochemie Cyprus, Curamed Germany,
Faulding Italy, DBL Australia, Farmauno Italy,
Merck Generics Italy, IPS Spain, Farmaplus Norway,
Dakota Sanofi Synthelabo France, Generis Spain,
Vita Spain, Caber Italy, Max Farma Italy,
Levo Farma Italy, Mayne Pharma Netherlsnds.
Pharmaceutical Forms
Product List
ANFARM offers a wide range of
products thus providing a solid base
for development both in the domestic
and overseas markets.
Pharmaceutical Categories
Anti-allergic: loratadine, sodium cromoglycate.
Anti-bacterial / Chemotherapeutics:
ciprofloxacine, norfloxacine.
Antibiotics: amikacin, doxycycline, amoxycilline,
ampicilline.
Anti-depressant / Anti-psycotic: sulpiride,
buspirone, fluoxetine.
Anti-diarrheal: nifuroxazide.
Cephalosporins
Cefatrizine
Cefixime
Cefotaxime
Ceftriaxone
Cefuroxime
Cefuroxime axetil
( Ceftazidime )
Lyophilization
Since 1993 we have been manufacturing
lyophilized products. Result of our
specialization plan.
Tenoxicam
Vecuronium bromide
Hydrocortisone
Omeprazole
Epilogue
ANFARM is utilizing and enjoying the
results of a successful five-year business
development plan. The Company is set on its
aim to become one of the leading Hellenic
manufacturing Companies, serving both the
domestic and international markets.
./.